- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05310617
Parental Project and Premature Ovarian Insufficiency (ParentIOP)
One of the main repercussions of POI is infertility. When the diagnosis of POI is announced, the question of fertility is addressed and the patient is often directed towards egg donation or adoption when she has a parental project. However, there are cases of spontaneous pregnancies after diagnosis.
This study was conducted to determine the proportion of patients with POI who were able to realize a parental project after diagnosis in the long term and by what means.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators propose to study patients with POI who were hospitalized in the endocrinology and reproductive medicine department of the Pitié-Salpêtrière Hospital for the etiological assessment of ovarian failure and its consequences between December 31, 1982 and January 12, 2021. The investigators will only include patients who were admitted to the day hospital because we have a complete etiological workup and a complete history for them, which allows investigators to describe the population properly. The patients must be over 18 years old at the time of the survey in order to be able to evaluate the presence of a parental project only in adult patients.
Patients for whom there is no valid contact information in the computer file (postal address or valid email address or cell phone number) or whose last consultation was more than 2 years ago will be excluded. Patients with Turner syndrome will be excluded because they may have comorbidities, particularly cardiac, that contraindicate pregnancy. Patients with POI secondary to oncological treatments (gonadotoxic chemotherapy or pelvic radiotherapy) will also be excluded because of the uncertain prognosis and the contraindications to pregnancy in case of hormone-dependent tumors.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75013
- Service d'endocrinologie et médecine de la reproduction
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients at least 18 years old at the time of the survey
- Patients with a diagnosis of PIO according to the current definition: cycle disturbances of more than 4 months and FSH > 25 on 2 measurements one month apart
- Patients having been hospitalized in day hospital (HDJ) in the endocrinology and reproductive medicine department of the Pitié-Salpêtrière hospital for the etiological assessment of ovarian insufficiency and its repercussions between December 31, 1982 and January 12, 2021
- Valid contact information available: address, cell phone, e-mail
- Patients who have been informed and do not object to participate in the study
Exclusion Criteria:
- Turner syndrome
- POI secondary to oncology treatments (chemotherapy, pelvic radiotherapy)
- Opposition to participating in the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Realisation of parental project
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Determine proportion of patient who realised a parental project after the diagnosis of POI
|
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determine how and to what extent they have carried out their parental project
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation if, after the diagnosis of POI, the parental project was realized through: spontaneous pregnancy or egg donation, simple stimulation or in vitro fertilization, embryo reception, or the adoption of a child after the diagnosis of POI
|
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
determine how many children on average these patients had after the diagnosis of POI.
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the number of children born after the diagnosis of POI
|
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
determine the delay between the diagnosis of POI and the birth of the first child after the diagnosis according to the method
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the time between the diagnosis of POI and the birth of the first child after diagnosis according to the method (egg donation, spontaneous pregnancy, adoption, etc.)
|
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o age at diagnosis |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o AMH level |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o FSH level |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o presence of follicles on ultrasound |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o cause of POI |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o number of pregnancies prior to diagnosis |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o number of children before diagnosis |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o normal puberty |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Survey. Describe the characteristics of patients who were able to have a child after diagnosis
Time Frame: data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Evaluation of the characteristics of patients who were able to have a child after diagnosis: o age at menarche |
data from patients with a diagnosis between 31/12/1982 and 12/01/2021 and whose opposition to the study is not expressed
|
Collaborators and Investigators
Investigators
- Principal Investigator: Philippe Touraine, Pr, APHP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP220208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Lawson Health Research InstituteCompletedEvaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation ParticipationMyocardial Infarction | Unstable Angina | Coronary Angioplasty | Coronary Artery Bypass SurgeryCanada
-
University GhentCompletedStroke | Upper Extremity Paresis | Survey
-
Assistance Publique - Hôpitaux de ParisUniversité de Cergy PontoiseCompleted
-
Weill Medical College of Cornell UniversityBoston Children's Hospital; Brigham and Women's Hospital; The Commonwealth FundCompletedPediatric ALLUnited States